The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (vol 9, 216, 2019)

Author(s):: Recourt, K.; Boer, P. de; Zuiker, R.; Luthringer, R.; Kent, J.; Ark, P. van der; Hove, I. van; Gerven, J. van; Jacobs, G.; Nueten, L. van; Drevets, W.

Published: 2019
Publication type: Other

Date issued: 2019-10-02
Language: English
Publisher: NATURE PUBLISHING GROUP
hdl: 1887/122465
doi: 10.1038/s41398-019-0585-4